NFKB1 and inflammatory bowel disease: It is worth mentioning that our study demonstrated for the first time that PXR deficiency alleviated the inflammatory response after SCI, whereas previous reports have suggested that pharmacological activation of PXR has anti‐inflammatory effects in inflammatory bowel disease through inhabiting NF‐kappaB signaling.71